🇸🇪 Tandem Health raises $100 million to bring European healthcare into the AI era

September 14, 2026

Tandem Health has raised $100 million in Series B funding, led by the Scaleup Europe Fund, managed by EQT. The company is the first healthcare AI company the Fund has backed. Existing investors Kinnevik, Northzone, Amino Collective and Visionaries are also participating in the Series B. It follows a $50 million Series A in 2025, bringing Tandem’s total funding to $160 million.

Tandem Health is used by 10,000 care organisations across 14 European markets and has certified three Class IIa medical devices under EU MDR in the past six months. Peer-reviewed research has shown that clinicians using Tandem report a 29% reduction in time spent on admin, 30% improvement in job satisfaction and a 30% reduction in administrative stress.

Tandem Health was founded on the principle that someone needs to take care of healthcare in Europe. The continent’s health systems face a widening gap between demand and workforce and the WHO estimates a shortfall of 1.6 million health and social care workers in 2024, rising to 4 million by 2030. To compound this, the number of Europeans over 65 will rise to around 130 million by 2050, cared for by a workforce that Eurostat projects will shrink to fewer than two working-age adults per retiree.

The current trajectory with rising healthcare costs, shortages of clinicians and an aging population is not sustainable. Tandem Health is addressing this issue by building clinically safe, regulatory-grade AI that clinicians can trust.

What Tandem Health offers

Tandem Health offers a complete AI Medical Assistant that supports clinicians before, during and after the patient visit. It prepares patient summaries ahead of appointments, provides clinical decision support during the consultation, and automatically handles the documentation, coding and task management that follows.

Tandem is the only AI Medical Assistant that has an AI Scribe, Coding Assistant, and Clinical Decision Support, each independently certified as Class IIa medical devices under the EU Medical Device Regulation. The company is also certified according to ISO 27001, ISO 13485, ISO 42001, C5 in Germany, ENS High in Spain, and HDS in France. Tandem is integrated with more than 130 medical record systems across Europe.

What’s next

The funding will go into two main areas. First, accelerating Tandem’s position as the AI partner of European care providers. Having already established offices in 14 European countries (Germany, France, UK, Spain, Italy, Netherlands, Sweden, Finland, Norway, Denmark, Belgium, Portugal, Estonia, Lithuania), Tandem will double down across European markets to further accelerate the adoption of AI in healthcare, supported by a clinician-led team of 100 in-house clinicians responsible for delivering, developing and tailoring the product to local needs.

Second, growing into an AI-native Clinic Operating System. Over the past year Tandem has grown from an AI Medical Scribe into a complete AI Medical Assistant. The next step is to support the broader clinic on their AI transformation journey, including patient flow management through triaging, scheduling and patient communications, as well as deeper integrations with other systems care providers utilise.

“Europe’s health systems are under real strain and AI presents a tangible solution. But until now, European care providers have had to depend either on legacy solutions or AI solutions originally built for other markets that were retrofitted for Europe. We started Tandem to provide an alternative. Europe should be setting the standard for how AI enters healthcare, not adopting someone else’s,” said Lukas Saari, CEO and co-founder of Tandem Health.

Contact

Katya Escala
PR & Comms at Tandem Health
[email protected]
+44 7784 097315

For more information, visit Tandem Health.

Originally published on September 14, 2026 by Tandem Health.